proline has been researched along with troglitazone in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (75.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ani, I; Buchanan, TA; Goico, J; Marroquin, A; Ochoa, C; Shuldiner, AR; Snitker, S; Watanabe, RM; Xiang, AH | 1 |
Anthwal, S; Arenberg, DA; Keshamouni, VG; Newstead, MJ; Reddy, RC; Standiford, TJ | 1 |
Altshuler, D; Delahanty, L; Florez, JC; Franks, PW; Hanson, RL; Jablonski, KA; Kahn, SE; Knowler, WC | 1 |
Chowdhury, AA; Ishikawa, T; Jisaka, M; Nagaya, T; Nishimura, K; Rahman, MS; Shono, F; Yokota, K | 1 |
2 trial(s) available for proline and troglitazone
Article | Year |
---|---|
Changes in insulin sensitivity in response to troglitazone do not differ between subjects with and without the common, functional Pro12Ala peroxisome proliferator-activated receptor-gamma2 gene variant: results from the Troglitazone in Prevention of Diabe
Topics: Alanine; Amino Acid Substitution; Blood Glucose; Chromans; Diabetes Mellitus, Type 2; DNA Primers; Female; Genetic Variation; Hispanic or Latino; Humans; Hypoglycemic Agents; Insulin; Polymerase Chain Reaction; PPAR gamma; Proline; Thiazolidinediones; Troglitazone | 2004 |
The Pro12Ala variant at the peroxisome proliferator-activated receptor gamma gene and change in obesity-related traits in the Diabetes Prevention Program.
Topics: Adult; Alanine; Amino Acid Substitution; Body Composition; Chromans; Diabetes Mellitus, Type 2; Dietary Fats; Eating; Female; Gene Frequency; Genotype; Humans; Hypoglycemic Agents; Life Style; Male; Metformin; Middle Aged; Obesity; Placebos; PPAR gamma; Proline; Thiazolidinediones; Troglitazone | 2007 |
2 other study(ies) available for proline and troglitazone
Article | Year |
---|---|
PPAR-gamma activation inhibits angiogenesis by blocking ELR+CXC chemokine production in non-small cell lung cancer.
Topics: Amino Acid Motifs; Animals; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Cells, Cultured; Chemokine CXCL1; Chemokine CXCL11; Chemokine CXCL5; Chemokines, CXC; Chemotaxis; Chromans; Culture Media, Conditioned; Dose-Response Relationship, Drug; Endothelium, Vascular; Enzyme-Linked Immunosorbent Assay; Factor VIII; Humans; Immunohistochemistry; Intercellular Signaling Peptides and Proteins; Interleukin-8; Ligands; Lung Neoplasms; Mice; Mice, SCID; Microcirculation; Neoplasm Transplantation; Neovascularization, Pathologic; NF-kappa B; Pioglitazone; PPAR gamma; Proline; Thiazolidinediones; Thiocarbamates; Transfection; Troglitazone | 2005 |
15-Deoxy-Δ(12,14)-prostaglandin J(2) interferes inducible synthesis of prostaglandins E(2) and F(2α) that suppress subsequent adipogenesis program in cultured preadipocytes.
Topics: 3T3-L1 Cells; Adipocytes; Adipogenesis; Animals; Arachidonic Acid; Calcimycin; Cell Proliferation; Chromans; Dinoprost; Dinoprostone; Gene Expression; Ionophores; Isoenzymes; Lipid Metabolism; Mice; NF-kappa B; PPAR gamma; Proline; Prostaglandin D2; Prostaglandin-Endoperoxide Synthases; Tetradecanoylphorbol Acetate; Thiazolidinediones; Thiocarbamates; Triglycerides; Troglitazone | 2011 |